Last reviewed · How we verify
Thiazide Treatment Group — Competitive Intelligence Brief
marketed
Thiazide diuretic
Sodium-chloride cotransporter (NCC)
Cardiovascular
Small molecule
Live · refreshed every 30 min
Target snapshot
Thiazide Treatment Group (Thiazide Treatment Group) — Cedars-Sinai Medical Center. Thiazide diuretics reduce blood pressure by decreasing sodium reabsorption in the distal convoluted tubule of the kidney, leading to increased sodium and water excretion and reduced blood volume.
Comparator set (6 drugs)
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| Thiazide Treatment Group TARGET | Thiazide Treatment Group | Cedars-Sinai Medical Center | marketed | Thiazide diuretic | Sodium-chloride cotransporter (NCC) | |
| olmesartan medoxomil-hydrochlorothiazide | OLMESARTAN | Cosette | marketed | Thiazide Diuretic [EPC] | 2019-01-01 | |
| Benicar | OLMESARTAN MEDOXOMIL | Cosette | marketed | Thiazide Diuretic [EPC] | Type-1 angiotensin II receptor | 2002-01-01 |
| Zestril | lisinopril | Generic (originally Merck/AstraZeneca) | marketed | Thiazide Diuretic [EPC] | Angiotensin-converting enzyme, Angiotensin-converting enzyme | 1987-12-29 |
| Capozide 25/15 | CAPTOPRIL | Aarxion Anda Hlding | marketed | Thiazide Diuretic [EPC] | Renin | 1981-01-01 |
| TRIAMTERENE | TRIAMTERENE | marketed | Thiazide Diuretic [EPC] | 1964-01-01 | ||
| Enduron | methylclothiazide | marketed | Thiazide Diuretic | Solute carrier family 12 member 3 | 1960-01-01 |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
- — Zestril · 9616096 · Method of Use · US
- — Zestril · 10039800 · Method of Use · US
- — Zestril · 10406199 · Method of Use · US
- — Zestril · 12433931 · Method of Use · US
- — Zestril · 10265370 · Formulation · US
- — Zestril · 9463183 · Formulation · US
- — Zestril · 11179434 · Formulation · US
- — Zestril · 9814751 · Formulation · US
- — Zestril · 10940177 · Formulation · US
- — Zestril · 11771733 · Formulation · US
- — Zestril · 12186360 · Formulation · US
- — Zestril · 12128083 · Formulation · US
Sponsor landscape (Thiazide diuretic class)
- Cedars-Sinai Medical Center · 2 drugs in this class
- National University of Ireland, Galway, Ireland · 1 drug in this class
- Bristol-Myers Squibb · 1 drug in this class
- Seiji Umemoto, M.D., Ph.D. · 1 drug in this class
- Takeda · 1 drug in this class
- University of Virginia · 1 drug in this class
- Novartis · 1 drug in this class
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- Thiazide Treatment Group CI watch — RSS
- Thiazide Treatment Group CI watch — Atom
- Thiazide Treatment Group CI watch — JSON
- Thiazide Treatment Group alone — RSS
- Whole Thiazide diuretic class — RSS
Cite this brief
Drug Landscape (2026). Thiazide Treatment Group — Competitive Intelligence Brief. https://druglandscape.com/ci/thiazide-treatment-group. Accessed 2026-05-16.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab